Cipla Discontinued
FDA Approved Drugs

Cipla Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 67
  • Latest Approval Date Jul 21, 2025
  • Data Source FDA
  • First Approval Date Sep 19, 2001
All
274
View
Unclassified
66
View
Discontinued
67
View
OTC
1
View
RX
140
View
Company Overview

Company

Cipla Discontinued

Country

India

Website

Visit Website

Email

corporate.one@cipla.com

Social Profiles

Company Snapshot

Cipla Discontinued

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra 400 013

India

www.cipla.com/ corporate.one@cipla.com View on Map
FDA Approved Drug Records ( 67 records )
2019
18 Jan
Discontinued Application: 211794

Drug Name

ACYCLOVIR

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2019-01-18

211794 / 1

Active Ingredient

ACYCLOVIR

Application Number

211794

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2019-01-18

Regulatory Status

Discontinued

2025
02 May
Discontinued Application: 212981

Drug Name

ACYCLOVIR

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2025-05-02

212981 / 1

Active Ingredient

ACYCLOVIR

Application Number

212981

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2025-05-02

Regulatory Status

Discontinued

2018
21 Sep
Discontinued Application: 210434

Drug Name

ALBENDAZOLE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2018-09-21

210434 / 1

Active Ingredient

ALBENDAZOLE

Application Number

210434

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2018-09-21

Regulatory Status

Discontinued

2011
29 Jun
Discontinued Application: 22434

Drug Name

ARGATROBAN IN SODIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-06-29

22434 / 1

Active Ingredient

ARGATROBAN

Application Number

22434

Product Number

1

Dosage Form

-

Strength

50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-06-29

Regulatory Status

Discontinued

2018
09 Aug
Discontinued Application: 200626

Drug Name

ATAZANAVIR SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2018-08-09

200626 / 1

Active Ingredient

ATAZANAVIR SULFATE

Application Number

200626

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2018-08-09

Regulatory Status

Discontinued

2018
09 Aug
Discontinued Application: 200626

Drug Name

ATAZANAVIR SULFATE

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-08-09

200626 / 2

Active Ingredient

ATAZANAVIR SULFATE

Application Number

200626

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-08-09

Regulatory Status

Discontinued

2018
09 Aug
Discontinued Application: 200626

Drug Name

ATAZANAVIR SULFATE

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2018-08-09

200626 / 3

Active Ingredient

ATAZANAVIR SULFATE

Application Number

200626

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2018-08-09

Regulatory Status

Discontinued

2018
09 Aug
Discontinued Application: 200626

Drug Name

ATAZANAVIR SULFATE

Product Number

4

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-08-09

200626 / 4

Active Ingredient

ATAZANAVIR SULFATE

Application Number

200626

Product Number

4

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-08-09

Regulatory Status

Discontinued

2024
10 Dec
Discontinued Application: 210352

Drug Name

BEXAROTENE

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2024-12-10

210352 / 1

Active Ingredient

BEXAROTENE

Application Number

210352

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2024-12-10

Regulatory Status

Discontinued

2019
11 Mar
Discontinued Application: 209439

Drug Name

BLEOMYCIN SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 15 UNITS BASE/VIAL

Approval Date

2019-03-11

209439 / 1

Active Ingredient

BLEOMYCIN SULFATE

Application Number

209439

Product Number

1

Dosage Form

-

Strength

EQ 15 UNITS BASE/VIAL

Approval Date

2019-03-11

Regulatory Status

Discontinued

2006
27 Jan
Discontinued Application: 77383

Drug Name

CARBOPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2006-01-27

77383 / 1

Active Ingredient

CARBOPLATIN

Application Number

77383

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2006-01-27

Regulatory Status

Discontinued

2006
27 Jan
Discontinued Application: 77383

Drug Name

CARBOPLATIN

Product Number

2

Dosage Form

-

Strength

150MG/VIAL

Approval Date

2006-01-27

77383 / 2

Active Ingredient

CARBOPLATIN

Application Number

77383

Product Number

2

Dosage Form

-

Strength

150MG/VIAL

Approval Date

2006-01-27

Regulatory Status

Discontinued

2006
27 Jan
Discontinued Application: 77383

Drug Name

CARBOPLATIN

Product Number

3

Dosage Form

-

Strength

450MG/VIAL

Approval Date

2006-01-27

77383 / 3

Active Ingredient

CARBOPLATIN

Application Number

77383

Product Number

3

Dosage Form

-

Strength

450MG/VIAL

Approval Date

2006-01-27

Regulatory Status

Discontinued

2018
12 Jul
Discontinued Application: 209489

Drug Name

CASPOFUNGIN ACETATE

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2018-07-12

209489 / 1

Active Ingredient

CASPOFUNGIN ACETATE

Application Number

209489

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2018-07-12

Regulatory Status

Discontinued

2018
12 Jul
Discontinued Application: 209489

Drug Name

CASPOFUNGIN ACETATE

Product Number

2

Dosage Form

-

Strength

70MG/VIAL

Approval Date

2018-07-12

209489 / 2

Active Ingredient

CASPOFUNGIN ACETATE

Application Number

209489

Product Number

2

Dosage Form

-

Strength

70MG/VIAL

Approval Date

2018-07-12

Regulatory Status

Discontinued

2013
25 Jul
Discontinued Application: 77318

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2013-07-25

77318 / 1

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

77318

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2013-07-25

Regulatory Status

Discontinued

2013
25 Jul
Discontinued Application: 77318

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2013-07-25

77318 / 2

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

77318

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2013-07-25

Regulatory Status

Discontinued

2017
16 Nov
Discontinued Application: 208601

Drug Name

DECITABINE

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2017-11-16

208601 / 1

Active Ingredient

DECITABINE

Application Number

208601

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2017-11-16

Regulatory Status

Discontinued

2020
11 Feb
Discontinued Application: 211852

Drug Name

DEFERASIROX

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2020-02-11

211852 / 1

Active Ingredient

DEFERASIROX

Application Number

211852

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2020-02-11

Regulatory Status

Discontinued

2020
11 Feb
Discontinued Application: 211852

Drug Name

DEFERASIROX

Product Number

2

Dosage Form

-

Strength

360MG

Approval Date

2020-02-11

211852 / 2

Active Ingredient

DEFERASIROX

Application Number

211852

Product Number

2

Dosage Form

-

Strength

360MG

Approval Date

2020-02-11

Regulatory Status

Discontinued

2020
15 Jun
Discontinued Application: 211852

Drug Name

DEFERASIROX

Product Number

3

Dosage Form

-

Strength

180MG

Approval Date

2020-06-15

211852 / 3

Active Ingredient

DEFERASIROX

Application Number

211852

Product Number

3

Dosage Form

-

Strength

180MG

Approval Date

2020-06-15

Regulatory Status

Discontinued

2024
20 Sep
Discontinued Application: 212334

Drug Name

DIHYDROERGOTAMINE MESYLATE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2024-09-20

212334 / 1

Active Ingredient

DIHYDROERGOTAMINE MESYLATE

Application Number

212334

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2024-09-20

Regulatory Status

Discontinued

2020
24 Sep
Discontinued Application: 210305

Drug Name

DIMETHYL FUMARATE

Product Number

1

Dosage Form

-

Strength

120MG

Approval Date

2020-09-24

210305 / 1

Active Ingredient

DIMETHYL FUMARATE

Application Number

210305

Product Number

1

Dosage Form

-

Strength

120MG

Approval Date

2020-09-24

Regulatory Status

Discontinued

2020
24 Sep
Discontinued Application: 210305

Drug Name

DIMETHYL FUMARATE

Product Number

2

Dosage Form

-

Strength

240MG

Approval Date

2020-09-24

210305 / 2

Active Ingredient

DIMETHYL FUMARATE

Application Number

210305

Product Number

2

Dosage Form

-

Strength

240MG

Approval Date

2020-09-24

Regulatory Status

Discontinued

2024
10 Dec
Discontinued Application: 212369

Drug Name

ELIGLUSTAT TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 84MG BASE

Approval Date

2024-12-10

212369 / 1

Active Ingredient

ELIGLUSTAT TARTRATE

Application Number

212369

Product Number

1

Dosage Form

-

Strength

EQ 84MG BASE

Approval Date

2024-12-10

Regulatory Status

Discontinued

2021
02 Apr
Discontinued Application: 90958

Drug Name

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

200MG;300MG

Approval Date

2021-04-02

90958 / 1

Active Ingredient

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Application Number

90958

Product Number

1

Dosage Form

-

Strength

200MG;300MG

Approval Date

2021-04-02

Regulatory Status

Discontinued

2015
26 Jan
Discontinued Application: 78003

Drug Name

ESOMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2015-01-26

78003 / 1

Active Ingredient

ESOMEPRAZOLE MAGNESIUM

Application Number

78003

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2015-01-26

Regulatory Status

Discontinued

2015
26 Jan
Discontinued Application: 78003

Drug Name

ESOMEPRAZOLE MAGNESIUM

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2015-01-26

78003 / 2

Active Ingredient

ESOMEPRAZOLE MAGNESIUM

Application Number

78003

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2015-01-26

Regulatory Status

Discontinued

2011
21 Mar
Discontinued Application: 78278

Drug Name

FAMCICLOVIR

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2011-03-21

78278 / 1

Active Ingredient

FAMCICLOVIR

Application Number

78278

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2011-03-21

Regulatory Status

Discontinued

2011
21 Mar
Discontinued Application: 78278

Drug Name

FAMCICLOVIR

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2011-03-21

78278 / 2

Active Ingredient

FAMCICLOVIR

Application Number

78278

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2011-03-21

Regulatory Status

Discontinued

2011
21 Mar
Discontinued Application: 78278

Drug Name

FAMCICLOVIR

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

2011-03-21

78278 / 3

Active Ingredient

FAMCICLOVIR

Application Number

78278

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

2011-03-21

Regulatory Status

Discontinued

2014
20 Nov
Discontinued Application: 77335

Drug Name

FINASTERIDE

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2014-11-20

77335 / 1

Active Ingredient

FINASTERIDE

Application Number

77335

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2014-11-20

Regulatory Status

Discontinued

2001
19 Sep
Discontinued Application: 75780

Drug Name

FLUTAMIDE

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2001-09-19

75780 / 1

Active Ingredient

FLUTAMIDE

Application Number

75780

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2001-09-19

Regulatory Status

Discontinued

2025
16 May
Discontinued Application: 211826

Drug Name

GEFITINIB

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2025-05-16

211826 / 1

Active Ingredient

GEFITINIB

Application Number

211826

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2025-05-16

Regulatory Status

Discontinued

2008
20 Feb
Discontinued Application: 77219

Drug Name

IRINOTECAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

40MG/2ML (20MG/ML)

Approval Date

2008-02-20

77219 / 1

Active Ingredient

IRINOTECAN HYDROCHLORIDE

Application Number

77219

Product Number

1

Dosage Form

-

Strength

40MG/2ML (20MG/ML)

Approval Date

2008-02-20

Regulatory Status

Discontinued

2008
20 Feb
Discontinued Application: 77219

Drug Name

IRINOTECAN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

100MG/5ML (20MG/ML)

Approval Date

2008-02-20

77219 / 2

Active Ingredient

IRINOTECAN HYDROCHLORIDE

Application Number

77219

Product Number

2

Dosage Form

-

Strength

100MG/5ML (20MG/ML)

Approval Date

2008-02-20

Regulatory Status

Discontinued

2018
12 Jun
Discontinued Application: 210322

Drug Name

ISOPROTERENOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2018-06-12

210322 / 1

Active Ingredient

ISOPROTERENOL HYDROCHLORIDE

Application Number

210322

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2018-06-12

Regulatory Status

Discontinued

2019
28 Jun
Discontinued Application: 211738

Drug Name

ISOPROTERENOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2019-06-28

211738 / 1

Active Ingredient

ISOPROTERENOL HYDROCHLORIDE

Application Number

211738

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2019-06-28

Regulatory Status

Discontinued

2019
25 Jan
Discontinued Application: 210335

Drug Name

MEDROXYPROGESTERONE ACETATE

Product Number

1

Dosage Form

-

Strength

150MG/ML

Approval Date

2019-01-25

210335 / 1

Active Ingredient

MEDROXYPROGESTERONE ACETATE

Application Number

210335

Product Number

1

Dosage Form

-

Strength

150MG/ML

Approval Date

2019-01-25

Regulatory Status

Discontinued

2015
15 Oct
Discontinued Application: 206448

Drug Name

NEVIRAPINE

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2015-10-15

206448 / 1

Active Ingredient

NEVIRAPINE

Application Number

206448

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2015-10-15

Regulatory Status

Discontinued

2018
19 Sep
Discontinued Application: 206396

Drug Name

PALONOSETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)

Approval Date

2018-09-19

206396 / 1

Active Ingredient

PALONOSETRON HYDROCHLORIDE

Application Number

206396

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)

Approval Date

2018-09-19

Regulatory Status

Discontinued

2022
22 Apr
Discontinued Application: 212424

Drug Name

PHYTONADIONE

Product Number

1

Dosage Form

-

Strength

1MG/0.5ML

Approval Date

2022-04-22

212424 / 1

Active Ingredient

PHYTONADIONE

Application Number

212424

Product Number

1

Dosage Form

-

Strength

1MG/0.5ML

Approval Date

2022-04-22

Regulatory Status

Discontinued

2022
22 Apr
Discontinued Application: 212424

Drug Name

PHYTONADIONE

Product Number

2

Dosage Form

-

Strength

10MG/ML

Approval Date

2022-04-22

212424 / 2

Active Ingredient

PHYTONADIONE

Application Number

212424

Product Number

2

Dosage Form

-

Strength

10MG/ML

Approval Date

2022-04-22

Regulatory Status

Discontinued

2020
10 Jan
Discontinued Application: 212280

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-01-10

212280 / 1

Active Ingredient

PREGABALIN

Application Number

212280

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-01-10

Regulatory Status

Discontinued

2020
10 Jan
Discontinued Application: 212280

Drug Name

PREGABALIN

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-01-10

212280 / 2

Active Ingredient

PREGABALIN

Application Number

212280

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-01-10

Regulatory Status

Discontinued

2020
10 Jan
Discontinued Application: 212280

Drug Name

PREGABALIN

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2020-01-10

212280 / 3

Active Ingredient

PREGABALIN

Application Number

212280

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2020-01-10

Regulatory Status

Discontinued

2020
10 Jan
Discontinued Application: 212280

Drug Name

PREGABALIN

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2020-01-10

212280 / 4

Active Ingredient

PREGABALIN

Application Number

212280

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2020-01-10

Regulatory Status

Discontinued

2020
10 Jan
Discontinued Application: 212280

Drug Name

PREGABALIN

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

2020-01-10

212280 / 5

Active Ingredient

PREGABALIN

Application Number

212280

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

2020-01-10

Regulatory Status

Discontinued

2020
10 Jan
Discontinued Application: 212280

Drug Name

PREGABALIN

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

2020-01-10

212280 / 6

Active Ingredient

PREGABALIN

Application Number

212280

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

2020-01-10

Regulatory Status

Discontinued

2020
10 Jan
Discontinued Application: 212280

Drug Name

PREGABALIN

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

2020-01-10

212280 / 7

Active Ingredient

PREGABALIN

Application Number

212280

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

2020-01-10

Regulatory Status

Discontinued

2020
10 Jan
Discontinued Application: 212280

Drug Name

PREGABALIN

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

2020-01-10

212280 / 8

Active Ingredient

PREGABALIN

Application Number

212280

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

2020-01-10

Regulatory Status

Discontinued

2008
07 Aug
Discontinued Application: 77004

Drug Name

RAMIPRIL

Product Number

1

Dosage Form

-

Strength

1.25MG

Approval Date

2008-08-07

77004 / 1

Active Ingredient

RAMIPRIL

Application Number

77004

Product Number

1

Dosage Form

-

Strength

1.25MG

Approval Date

2008-08-07

Regulatory Status

Discontinued

2008
07 Aug
Discontinued Application: 77004

Drug Name

RAMIPRIL

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2008-08-07

77004 / 2

Active Ingredient

RAMIPRIL

Application Number

77004

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2008-08-07

Regulatory Status

Discontinued

2008
07 Aug
Discontinued Application: 77004

Drug Name

RAMIPRIL

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2008-08-07

77004 / 3

Active Ingredient

RAMIPRIL

Application Number

77004

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2008-08-07

Regulatory Status

Discontinued

2008
07 Aug
Discontinued Application: 77004

Drug Name

RAMIPRIL

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2008-08-07

77004 / 4

Active Ingredient

RAMIPRIL

Application Number

77004

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2008-08-07

Regulatory Status

Discontinued

2019
28 May
Discontinued Application: 211291

Drug Name

RANOLAZINE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2019-05-28

211291 / 1

Active Ingredient

RANOLAZINE

Application Number

211291

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2019-05-28

Regulatory Status

Discontinued

2019
28 May
Discontinued Application: 211291

Drug Name

RANOLAZINE

Product Number

2

Dosage Form

-

Strength

1GM

Approval Date

2019-05-28

211291 / 2

Active Ingredient

RANOLAZINE

Application Number

211291

Product Number

2

Dosage Form

-

Strength

1GM

Approval Date

2019-05-28

Regulatory Status

Discontinued

2025
21 Jul
Discontinued Application: 218661

Drug Name

SELENIOUS ACID

Product Number

1

Dosage Form

-

Strength

EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML)

Approval Date

2025-07-21

218661 / 1

Active Ingredient

SELENIOUS ACID

Application Number

218661

Product Number

1

Dosage Form

-

Strength

EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML)

Approval Date

2025-07-21

Regulatory Status

Discontinued

2025
21 Jul
Discontinued Application: 218661

Drug Name

SELENIOUS ACID

Product Number

2

Dosage Form

-

Strength

EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML)

Approval Date

2025-07-21

218661 / 2

Active Ingredient

SELENIOUS ACID

Application Number

218661

Product Number

2

Dosage Form

-

Strength

EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML)

Approval Date

2025-07-21

Regulatory Status

Discontinued

2018
16 Jul
Discontinued Application: 210855

Drug Name

SODIUM NITROPRUSSIDE

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

2018-07-16

210855 / 1

Active Ingredient

SODIUM NITROPRUSSIDE

Application Number

210855

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

2018-07-16

Regulatory Status

Discontinued

2019
20 May
Discontinued Application: 209839

Drug Name

SOLIFENACIN SUCCINATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-05-20

209839 / 1

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

209839

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-05-20

Regulatory Status

Discontinued

2019
20 May
Discontinued Application: 209839

Drug Name

SOLIFENACIN SUCCINATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2019-05-20

209839 / 2

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

209839

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2019-05-20

Regulatory Status

Discontinued

2009
20 Mar
Discontinued Application: 78030

Drug Name

STAVUDINE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2009-03-20

78030 / 1

Active Ingredient

STAVUDINE

Application Number

78030

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2009-03-20

Regulatory Status

Discontinued

2021
09 Feb
Discontinued Application: 212224

Drug Name

TAVABOROLE

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2021-02-09

212224 / 1

Active Ingredient

TAVABOROLE

Application Number

212224

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2021-02-09

Regulatory Status

Discontinued

2010
24 May
Discontinued Application: 77135

Drug Name

VALACYCLOVIR HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2010-05-24

77135 / 1

Active Ingredient

VALACYCLOVIR HYDROCHLORIDE

Application Number

77135

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2010-05-24

Regulatory Status

Discontinued

2010
24 May
Discontinued Application: 77135

Drug Name

VALACYCLOVIR HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE

Approval Date

2010-05-24

77135 / 2

Active Ingredient

VALACYCLOVIR HYDROCHLORIDE

Application Number

77135

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE

Approval Date

2010-05-24

Regulatory Status

Discontinued

2018
09 Nov
Discontinued Application: 209672

Drug Name

VALGANCICLOVIR HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 450MG BASE

Approval Date

2018-11-09

209672 / 1

Active Ingredient

VALGANCICLOVIR HYDROCHLORIDE

Application Number

209672

Product Number

1

Dosage Form

-

Strength

EQ 450MG BASE

Approval Date

2018-11-09

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    41 View
  • EDQM CEP
    100 View
  • KDMF
    0 View
  • Japan DMF
    6 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    274 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
67 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACYCLOVIR

Application Number

211794

Product Number

1

Active Ingredient

ACYCLOVIR

Dosage Form

-

Strength

5%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit